Add-on Intravenous Immunoglobulins in Early Myositis
Add-on Intravenous Immunoglobulins in Early Myositis
Active, not recruiting · NCT05832034 · Registry updated 2026-02-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Add-on Intravenous Immunoglobulins in Early Myositis | Skin and Connective Tissue Diseases, acquired idiopathic inflammatory myopathy, antisynthetase syndrome, connective tissue disorder, dermatomyositis, immune-mediated necrotizing myopathy, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, polymyositis, skin disorder | Active, not recruiting | Phase 2 / Phase 3 | 2026-02-27 | NCT05832034 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 199 |
| Princess Beatrix Muscle Foundation | 2 |
| Prothya Biosolutions | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Department of Neurology, Amsterdam UMC, location AMC | Amsterdam | Netherlands | 1 |